Observational studyPloS one2026

Rivaroxaban treatment discontinuation rates in patients with nonvalvular atrial fibrillation in Italian clinical practice: RITMUS-AF.

Carmine Pizzi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.